CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,385 | +2645.2% | 1,903,701 | +1916.2% | 0.00% | – |
| Q2 2023 | $1,034 | +63.1% | 94,421 | +30.0% | 0.00% | – |
| Q1 2023 | $634 | -21.8% | 72,611 | -43.9% | 0.00% | – |
| Q4 2022 | $811 | -99.9% | 129,417 | -26.1% | 0.00% | – |
| Q3 2022 | $613,000 | +70.3% | 175,100 | +43.3% | 0.00% | – |
| Q2 2022 | $360,000 | +5.3% | 122,200 | +11.0% | 0.00% | – |
| Q1 2022 | $342,000 | +4.6% | 110,123 | +13.9% | 0.00% | – |
| Q4 2021 | $327,000 | -34.9% | 96,651 | -29.7% | 0.00% | – |
| Q3 2021 | $502,000 | -16.3% | 137,574 | 0.0% | 0.00% | – |
| Q2 2021 | $600,000 | +90.5% | 137,574 | +98.4% | 0.00% | – |
| Q1 2021 | $315,000 | +14.5% | 69,335 | +44.6% | 0.00% | – |
| Q4 2020 | $275,000 | +60.8% | 47,958 | +103.6% | 0.00% | – |
| Q3 2020 | $171,000 | -96.2% | 23,558 | -94.3% | 0.00% | -100.0% |
| Q3 2018 | $4,554,000 | -50.6% | 410,967 | -40.2% | 0.00% | 0.0% |
| Q2 2018 | $9,223,000 | +1.4% | 687,277 | -1.8% | 0.00% | 0.0% |
| Q1 2018 | $9,094,000 | – | 700,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |